NS-089/NCNP-02 Preclinical Data Published in Molecular Therapy Nucleic Acids

/PRNewswire/ -- NS Pharma, Inc. announced today the publication of preclinical data on NS-089/NCNP-02 (brogidirsen), an investigational candidate for patients...

Related Keywords

United States ,Kodaira ,Tokyo ,Japan ,Kazuyuki Nakagome ,Tsugio Tanaka ,Toru Nakai ,National Center ,Ns Pharma Inc ,Drug Administration ,Nippon Shinyaku Co Ltd ,Nippon Shinyaku ,Molecular Therapy Nucleic ,Kodaira City ,Rare Pediatric Disease ,Breakthrough Therapy ,Orphan Drug Designations ,Duchenne Muscular Dystrophy ,Rns Pharma ,Health Care Amp Hospitals ,Medical Pharmaceuticals ,Pharmaceuticals ,Clinical Trials Amp Medical Discoveries ,